Gate News message, April 15 — Anthropic announced that its Long-Term Benefit Trust has appointed Novartis CEO Vas Narasimhan to the AI company’s board. The move gives trust-appointed directors a majority on the board and adds healthcare industry expertise to the company’s governance.
Narasimhan, a physician-scientist and chief executive of Novartis, joins existing directors including Dario Amodei, Daniela Amodei, Yasmin Razavi, Jay Kreps, Reed Hastings, and Chris Liddell. Anthropic cited his experience in regulated industries and drug development as key qualifications.
Anthropic operates as a Delaware Public Benefit Corporation, a legal structure that allows its board to balance stockholder returns with its public benefit mission of responsibly developing advanced AI. The Long-Term Benefit Trust is an independent body with no financial stake, designed to help balance shareholder interests with the company’s long-term goals. Major investors such as Google and Amazon, which have invested billions, do not hold voting shares and cannot elect board members.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
Related Articles
Novo Nordisk Partners with OpenAI to Accelerate Drug Development Using AI
Novo Nordisk has partnered with OpenAI to enhance drug development and AI integration in operations. The collaboration aims to speed up drug candidate analysis and employee training, potentially transforming obesity and diabetes research and beyond.
GateNews34m ago
OpenAI Exits Norway Stargate Project, Microsoft Takes Over Data Center Lease
OpenAI has withdrawn from the Stargate data center project in Norway, shifting focus amid regulatory challenges and costs. British startup Ensacle will lease the facility to Microsoft, aiming to meet increasing AI demands in Europe.
GateNews54m ago
Texas Grid Operator Warns Power Demand Could Quadruple by 2032 as AI Data Centers Drive Energy Surge
ERCOT warns Texas's power demand may quadruple by 2032, driven by AI data centers and population growth, potentially requiring capacity equivalent to 300 new nuclear reactors. Major tech companies are adopting self-supply models with long-term power agreements, while challenges like grid capacity and costs remain.
GateNews1h ago
OpenAI, Anthropic, and Google Team Up to Combat AI Model Distillation by Chinese Competitors
OpenAI, Anthropic, and Google are collaborating to combat Chinese competitors’ efforts to enhance AI capabilities by extracting outputs from U.S. models, sharing information through the Frontier Model Forum to address adversarial data distillation.
GateNews1h ago
Waymo Expands Robotaxi Service to Miami and Orlando, Launches Highway Testing in Miami
Waymo has expanded its Robotaxi service to all passengers in Miami and Orlando, transitioning from an invite-only model. The company also began road testing on Miami highways, showcasing its autonomous driving technology.
GateNews2h ago
Allbirds Stock Soars 582% After Announcing AI Pivot, $50M Funding Round
Allbirds announced a transformation to become NewBird AI, securing $50 million in convertible financing to focus on AI computing infrastructure. This decision follows declining sales and a brand sale. Stock surged 582%, but concerns about market competition and valuation bubbles persist.
GateNews2h ago
